Skip to main content
Toggle navigation
Search
Home
Back
Like
Email
Post
Andrew W. Zarker, MD
McGovern Medical School at UTHealth
Poster(s):
P2692 - Combination Vedolizumab and Ustekinumab for Refractory Crohn’s Disease After Immune Checkpoint Inhibitors
Monday, October 28, 2024
10:30 AM – 4:00 PM
ET
Email Andrew